Pfizer gave more than $10 million to a charity for heart patients while dramatically increasing the price of one of its antiarrhythmic drugs, deflecting costs from patients and leaving Medicare with a bigger bill, the U.S. Justice Department said in a May 24 settlement statement.
May 25, 2018 | Hypertension
Total adherence to the 2017 hypertension guidelines would result in about 330,000 fewer deaths each year in the U.S., according to a study published May 23 in JAMA Cardiology.
May 24, 2018 | Healthcare Economics
Once more expensive P2Y12 inhibitors hit the U.S. market, the percentage of patients not filling prescriptions for any P2Y12 inhibitor after percutaneous coronary intervention (PCI) increased from 6 percent to 19 percent, researchers reported in JAMA Internal Medicine.
May 21, 2018 | Policy
In an opinion piece for USA Today, musician and actress Barbra Streisand noted inequalities for women in heart disease research and treatment—resulting in more deaths from cardiovascular disease.
May 21, 2018 | Healthcare Economics
Haider Warraich, MD, used the recently presented CABANA trial to launch into an opinion piece about the medical community’s eagerness to embrace new technologies and invasive procedures.
May 18, 2018 | Healthcare Economics
The National Institutes of Health (NIH) has halted enrollment in a $100 million, 10-year study of moderate alcohol intake and its effect on cardiovascular health amid concerns over conflicts of interest with the beverage industry.
May 14, 2018 | Lipids & Metabolic
The World Health Organization (WHO) is challenging all nations to rid their foods of artificial trans fats in the next five years, a move expected to curb the burden of cardiovascular disease worldwide. This task would likely require countries to use regulations or legislation to force food manufacturers to make the switch.
May 13, 2018 | Healthcare Economics
Accelerating the integration of digital healthcare tools in a responsible, clinically meaningful way is the primary focus of the American College of Cardiology’s (ACC) innovation agenda, according to John Rumsfeld, MD, PhD, who spoke at the 2018 Cardiovascular Summit in February.
May 13, 2018 | Healthcare Economics
The entry of new players and dozens of potentially disruptive mergers and acquisitions are pushing healthcare in nontraditional directions, yielding opportunities for cardiologists to help shape the transformation.
May 10, 2018 | Healthcare Economics
CMS Administrator Seema Verma, MPH, said accountable care organizations (ACOs) that haven’t taken on downside risk “are not producing results,” suggesting the agency could reevaluate those payment models.
Requiring hospitals and physicians to publicly report their mortality outcomes related to percutaneous coronary intervention (PCI) causes many interventional cardiologists to forego high-risk procedures, researchers reported in JAMA Cardiology.
May 08, 2018 | Practice Management
Some cardiovascular practices have begun using time value units (TVUs) to level the playing field between specialties and better account for non-relative value unit (RVU) activities that may still be important to care delivery.
Recent studies have shown closing a patent foramen ovale (PFO) in select patients after cryptogenic stroke is associated with a lower risk of recurrent stroke. Now, according to a new analysis in Stroke, PFO occlusion in combination with antiplatelet treatment appears to be cost-effective when compared to medical therapy alone.
May 03, 2018 | Healthcare Economics
The absence of atherosclerotic cardiovascular diseases (ASCVD) and a favorable cardiovascular modifiable risk factor (CRF) are associated with “significantly” lower costs among cancer patients, according to a study published May 1 in the Journal of the American Heart Association.
Abbott’s XIENCE Sierra, the newest generation of the company’s everolimus-eluting coronary stent, has been approved for national reimbursement in Japan.
May 01, 2018 | Healthcare Economics
New research suggests people exhibiting ST-segment elevation myocardial infarction (STEMI) receive life-saving treatment more quickly if they live in states that allow emergency medical services (EMS) to take patients straight to hospitals that offer specialized treatment, rather than those that do not.
May 01, 2018 | Healthcare Economics
A new study analyzed the “substantial” cost burden to state and federal healthcare programs from patients hospitalized with endocarditis because of drug abuse. Findings were presented April 26 at the Society for Cardiovascular Angiography and Interventions (SCAI) 2018 Scientific Sessions in San Diego.
Apr 25, 2018 | Healthcare Economics
A new CMS proposal will require hospitals to post their standard prices for treatments online and aims to increase patient access to electronic health records.
Apr 19, 2018 | Healthcare Economics
Cardiologists earn an average of $423,000 annually, according to the 2018 Medscape Cardiologist Compensation Report, up from $410,000 in last year’s survey. That salary puts cardiology third among all specialties—behind only plastic surgery ($501,000) and orthopedics ($497,000).
Apr 19, 2018 | Healthcare Economics
The FDA’s voluntary sodium reduction goals for packaged and processed foods could greatly reduce or delay deaths from cardiovascular disease (CVD) in the U.S. and are cost-saving even in pessimistic simulations, according to a study published online April 10 in PLOS Medicine.
Apr 18, 2018 | Lipids & Metabolic
A team of researchers from Geisinger Health System in Pennsylvania are attempting to curb diabetes among their patient population with a program that treats healthy food like a prescription drug—and it has delivered strong early results.